Jeff Kearns

Jeff Kearns

Company: Novartis AG

Job title: Translational Modeling & Simulation Lead

Seminars:

QSP Modeling of a Transiently Inactivating ADC Highlights Benefit of Short Antibody Half Life 10:00 am

Reviewing a case study of a targeted ADC with transiently inactivating payload Understanding the impact of decoupled antibody and payload kinetics on modeling and bioanalytical strategies Evaluating MID3 approaches for design to human dose prediction for targeted ADCsRead more

day: Conference Day 1

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.